Respiratory Impairment and Disability A. H. Mehrparvar, M.D.

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Pulmonary Function Testing
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Bronchoprovocation test Presented by: Ashraf Abbas ELMaraghy,MD. Lecturer of Chest Diseases, Ain Shams University.
Academy Board Prep PCCM
Bronchial Asthma in the Elderly Presented by: Dr. Naif Shroof FRCP, FACCP, FACP Prof of medicine Jordan University Hospital.
Physiology Lab Spirometry
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Professor of Respiratory Medicine
LUNG FUNCTION IN HEALTH AND DISEASE: SPIROMETRY Sultan Ayoub Meo MBBS, PGC Med Ed, PG Dip Med Ed, M.Phil, Ph.D Professor, Department of Physiology, College.
Pre-Operation Evaluation of Thoracic Surgery Patient: Spirometry and Pulmonary Exercise test (PXT) 吳惠東.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Bronchial provocation Tests or Bronchial challenge Test
Asthma What is Asthma ? V1.0 1997 Merck & ..
Management of Patients With Chronic Pulmonary Disease.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
COPD Management of Stable COPD Shyam Rao May 2014.
Diagnosing asthma History & Physical examination Measurements of lung function – Spirometry – Peak expiratory flow Measurements of airway hyperresponsiveness.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Respiratory Function Tests Fiona Gilmour SHO 03/06/04.
Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.
Spirometry (Pulmonary Function Tests)
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Respiratory COPD/Asthma.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Quality of Life & Disability Assessment Kenneth D. Rosenman, MD Professor of Medicine Michigan State University.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Normal and abnormal Prof. J. Hanacek, MD, PhD
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
LUNG FUNCTIONS IN HEALTH AND DISEASE Prof. Sultan Ayoub Meo MBBS, M.Phil, Ph.D (Pak), PG Dip Med Ed (Scotland) FRCP (London), FRCP (Dublin), FRCP (Glasgow),
1 Pulmonary Function Tests J.B. Handler, M.D. Physician Assistant Program University of New England.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Pulmonary Function David Zanghi M.S., MBA, ATC/L, CSCS.
Pulmonary Function Measurements
Chronic Obstructive Pulmonary Disease
Pulmonary Function Tests Eloise Harman. Symptoms of Lung Disease Cough, productive or unproductive Increased sensitivity to odors and irritants Pleuritic.
PULMONARY FUNCTION TESTING By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS)
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Maggie Harris Independent Respiratory Nurse Specialist
Clinical Application of Pulmonary Function Tests Sevda Özdoğan MD, Prof. Chest Diseases.
Definition of asthma Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory.
Pulmonary function test. Evaluation of pulmonary function is important in many clinical situations evaluation of a variety of forms of lung disease assessing.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Masqueraders of Asthma: Differential Diagnosis of Asthma in Adults George Su, MD SFGH/UCSF Division of Pulmonary and Critical Care San Francisco Asthma.
Pulmonary function tests & Lung volumes & capacities Prof. Omer Abdel Aziz.
Clinical Applications of Spirometry for Pediatric Asthma
PULMONARY FUNCTION TESTS D.mohamed said
Sandra D. Anderson and John D. Brannan Department of Respiratory & Sleep Medicine, Royal Prince Alfred Hospital, New South Wales, Australia Current Opinion.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Respiratory Problems - 1
By: James Simpson.  Why  What – now featuring definitions  When  Interpretation  CA$H MONEY.
COPD 2003.
Chronic Obstructive Pulmonary Disease(COPD)
Respiratory Functions and Diseases
Lung function in health and disease
Pulmonary Function Tests
COPD Dr MAMATHA SARTHI GPST3.
Division of Pulmonary, Critical Care and Sleep Medicine
Interpretation Normal Spirometry Obstructive pattern
Presentation transcript:

Respiratory Impairment and Disability A. H. Mehrparvar, M.D.

References Anderson, Cocchiarella; Guides to the evaluation of permanent impairment, 5 th edition, “Guidelines for the evaluation of impairment / disability in patients with asthma”, ATS criteria, W. N. Rom; Environmental and occupational medicine, 3 rd. Edition, Abramson, Burden, Field; “Evaluation of impairment, disability, and handicapcaused by respiratory disease” Thoracic society of Australia and New Zealand, 1992.

Respiratory system consists of: Tracheobronchial tree Pulmonary parenchyma Rib cage

Impairment and Disability Impairment: a loss, loss of use, or derangement of any body part, organ system or organ function (a medical issue) Disability: absence from work or loss of work attributed to a medical condition (a non-medical issue) (disability is a term used to indicate the total effect of impairment on the patient’s life)

Impairment percentage or rating Estimates that reflect the severity of the medical condition and the degree to which the impairment decreases an individual’s ability to perform common daily activities, excluding work.

Important data for impairment evaluation History (occupational and non- occupational) Physical examination Imaging Lab data PFT

Symptoms associated with respiratory diseases Dyspnea: The most common, non-specific Cough, Sputum, Hemoptysis Wheezing Thoracic cage abnormalities

Examinations Respiratory rate Use of accessory muscles Respiratory sounds (crakle, Wheezing,…) Respiratory pattern (e.g. pursed lips,…) Chest wall abnormalities And …

Imaging Chest X ray (AP and lateral in full inspiration) CT, HRCT

Other tests Spirometry (the most beneficial test in evaluating functional changes) DLCO Cardiopulmonary exercise testing (V O2 max) ABG

Cardiopulmonary exercise testing (Vo 2 max) Exercise capacity is measured by oxygen consumption per unit time (Vo 2 ) in ml/(kg.min) or in metabolic equivalents (METS) 1 METS = 3.5 ml/(kg.min) An individual can sustain a work level equal to 40% of Vo 2 max for an 8-hour period.

Cardiopulmonary exercise testing (Vo 2 max, Cont.) Work intensityO 2 consumptionExcess energy expenditure Light work 7ml/kg; 0.5 L/min <2 METS Moderate work 8-15ml/kg; L/min 2-4 METS Heave work ml/kg; L/min 5-6 METS Very heavy work 21-30ml/kg; L/min 7-8 METS Arduous work >30ml/kg; >2.0 L/min >8 METS

Permanent impairment due to respiratory disorders (whole person) Class 1 (0% impairment) Class 2 (10%– 25% impairment) Class 3 (26%– 50% impairment) Class 4 (51%-100% impairment)

Class 1 FVC and FEV 1 and FEV 1 /FVC ≧ lower limit of normal And DL CO ≧ lower limit of normal Or V O2 max ≧ 25 ml/ kg.min (7.1 METS)

Class 2 FVC or FEV 1 ≧ 60% of predicted and < lower limit of normal or DL CO ≧ 60% of predicted and < lower limit of normal or 20 ≦ V O2 max < 25 ml/ kg.min ( METS )

Class 3 51% ≦ FVC ≦ 59% of predicted or 41% ≦ FEV 1 ≦ 59% of predicted or 41% ≦ DL CO ≦ 59% of predicted or 15 ≦ V O2 max ≦ 20 ml/ kg.min (4.3 < METS < 5.7)

Class 4 FVC ≦ 50% of predicted or FEV 1 ≦ 40% of predicted or DL CO ≦ 40% of predicted or V O2 max< 15 ml/ kg.min (< 4.3 METS)

Asthma Diagnosis of asthma requires: 1. Relevant symptoms and signs (cough, sputum, wheeze,…) 2. Evidence of airflow obstruction (partially or completely reversible) or airway reactivity to methacholine

Evaluation of impairment in asthma 1. Spirometry (before and after bronchodilator) 2. Challenge test

Measurement of spirometry Spirometric measurements should be made after withholding inhaled bronchodilators for 8 hours and long-acting bronchodilators for 24 hours. Antiinflammatory drugs such as cromolyn, inhaled or systemic corticosteroids should not be withheld.

Measurement of spirometry (Cont.) FEV1, FVC and FEV1/FVC is measured If: FEV1/FVC < lower limit of normal Then: repeat spirometry after administration of an inhaled bronchodilator Improvement in FEV1 of 12%, with an absolute change of 200 ml from baseline indicates reversibility

Measurement of spirometry (Cont.) If: improvement in FEV1 <12% Then: Begin steroid therapy (>800 mcg beclomethasone /day) Improvement in FEV1 of 20%, indicates reversibility

Airway hyperresponsiveness (bronchial challenge test) Measurement of airway responsiveness is needed for diagnosis and impairment rating if subject has no current evidence of airflow limitation. The test should be done after withholding inhaled short-acting bronchodilators for 6 hours and long- acting for 24 hours. The provocation concentration to cause a fall in FEV1 of 20% (PC20).

Airway hyperresponsiveness (bronchial challenge test, Cont.) If PC 20 is ≦ 8 mg/ml methacholine or histamine, hyperresponsiveness is considered.

Parameters for impairment evaluation in asthma FEV1 % of FEV1 change (reversibility) PC20 mg/ml Minimum medications

Score 0 FEV1 ≧ lower limit of normal Reversibility <10% PC20 > 8 mg/ml No medication

Score 1 FEV1 ≧ 70% of predicted 10% < Reversibility < 19% 0.6 mg/ml < PC20 < 8 mg/ml Occasional but not daily bronchodilator or cromolyn

Score 2 60% < FEV1< 69% 20% <Reversibility < 29% mg/ml <PC20 < 0.6 mg/ml Daily bronchodilator or cromolyn or daily low-dose inhaled corticosteroid

Score 3 50% < FEV1< 59% 20% ≦ Reversibility PC20 ≦ mg/ml Bronchodilator (PRN) or daily high-dose inhaled corticosteroid (800mcg beclomethasone) or occasional systemic corticosteroid

Score 4 FEV1 < 50% of predicted Bronchodilator (PRN) or daily high-dose inhaled corticosteroid (>1000 mcg beclomethasone) or daily or every other day systemic corticosteroid

Impairment rating for asthma Total asthma score % Impairment Class Imp. Of the whole person 010% % % (or asthma uncontrollable despite maximal treatment) %

Types of impairment/disability in asthma 1. Temporary: after diagnosis of occupational asthma, the patient is 100% impaired for the job that has caused the symptoms and treatment is to remove the worker from exposure. 2. Permanent: assessment for permanent impairment should be done 2 years after the removal from exposure.

Sleep apnea For grading sleep apnea: 1. Number of apnea / hypopnea episodes in polysomnography 2. Severity of hypoxia There is no standard for impairment rating., only judgment of a sleep specialist is important.